The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
ICER Assesses Cost-Effectiveness of Trained Service Dogs for Veterans with PTSD
The U.S. Department of Veterans Affairs (VA) commissioned the Institute for Clinical and Economic Review (ICER) to assess the cost-effectiveness [...]
Cytel Scientists Call for a “Statistician-First Workflow” to Optimize Drug Development
Adaptive trial designs within oncology are described by Cytel scientists, and address data, statistical, and commercial and scientific value of [...]
Optimized Value Analytics – The Next Frontier for Payers and Pharma?
By Caitlin Rothermel, MA, MPHc Introduction If you’ve been following the health economics industry for the past few years, you’ve heard [...]